Currently predicting for Thu, 4 Jun 2026

ATAI Prediction Chart

ATAI Predictions History

Latest community submissions for ATAI.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 5, 2026 $9.64 +149.10% Unrealistic Excluded from avg $3.87 X 0.00% 0
Jan 5, 2026 Bullish $3.87 X 0
Dec 29, 2025 $4.18 +2.62% $4.00 X 95.59% 0
Dec 29, 2025 $4.14 +1.64% $4.00 X 96.59% 0
Dec 29, 2025 $12.29 +201.97% Unrealistic Excluded from avg $4.00 X 0.00% 0
Dec 2, 2025 $3.72 -3.10% $3.87 X 96.15% 0
Dec 2, 2025 $3.77 -1.94% $3.87 X 97.30% 0
Dec 2, 2025 Bearish $3.87 X 0
Dec 2, 2025 Bullish $3.87 X 1
Dec 1, 2025 $3.77 -3.15% $3.84 V 98.11% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATAI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ATA INC.
ATA
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modul...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE